The Bailis lab aims to understand how metabolism underlies immunology and disease, by controlling the biochemistry of cells and tissues. We do so using in vitro and in vivo CRISPR engineering of primary human and mouse immune cells. Together with next generation sequencing and metabolomics, this permits us to fully interrogate how metabolic networks control immune cell function. Our long-term goal is to use this to develop novel diet and metabolite based therapies.